Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by chance18on Apr 06, 2020 3:17pm
203 Views
Post# 30884080

Worth a look !

Worth a look !“I have been a Bioasis shareholder for "8" years largely due to Graeme throughout the highs and lows, he has always maintained a professional attitude and continues to remain optimistic. Today, one of Graeme's other clients ,Magnetic North (V.MNC ) announced a multi -year agreement with its investee company , Previcare and a major distributor that serves global retailers and drug store chains throughout North America. Previcare's EPA and FDA registered hand sanitizer is effective in killing the 2019 -nCoV Wuhan Coronavirus on hard surfaces .MNC expects Previcare to generate $30 mm in revenue this calendar year. I know this is a BTI board but I thought I would share this . I believe it's worth checking out while we wait for news here . Good luck to all in these difficult times and stay safe !
Bullboard Posts